Findings reveal cognitive impairments in young patients, suggesting vorinostat doesn't worsen cognitive deficits post-transplant.
Results highlight cognitive impairments present prior to transplant and support prior findings in an adult population, suggesting that vorinostat does not result in additional cognitive or psychological deficits following transplant.
No takes yet. Share an insight, caveat, or question.
Votruba et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: